Goji Group - Research Trials Group

Miami Lakes, Florida 33016

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease, Crohn's Disease

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed